Literature DB >> 1811164

The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study.

G R Dodge1, I Pidoux, A R Poole.   

Abstract

Rabbit antibodies were prepared that react only with denatured type II collagen alpha-chains and cleavage products. The epitopes that these antibodies recognize reside in cyanogen bromide peptides CB8 and CB11. The antibodies do not react with triple helical collagen nor with any other collagen or protein present in hyaline cartilage (Dodge and Poole, J. Clin. Invest. 83:647-661, 1989). These antibodies can therefore be used to detect denatured type II collagen produced, for example, by enzymatic cleavage. In this study they were used to determine, at the ultrastructural level, using immunogold staining, type II collagen fibril cleavage in articular cartilages remote from synovium and pannus of patients with rheumatoid arthritis. Comparisons were made with site- and age-matched healthy articular cartilages. Antibody binding was detected in the extracellular matrix, at the articular surface and in the deep zone, usually on visibly damaged collagen fibrils which exhibited a loss of the normal banding pattern of staining produced by lead citrate and uranyl acetate: binding was also observed in disrupted fibrils, sometimes at their ends. Binding was commonly associated with amorphous-looking material (and occasionally unstained sites) in the extracellular matrix which, because of the specificity of the antibody, can be identified as containing denatured or fragmented type II collagen, stained (and unstained) with heavy metals. In both rheumatoid and healthy articular cartilages, there was no antibody binding to intact well stained fibrils which exhibited a regular banding pattern. Little or no staining was detected at the ultrastructural level in normal cartilages.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1811164     DOI: 10.1016/s0934-8832(11)80204-0

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  12 in total

1.  Cartilage quality in rheumatoid arthritis: comparison of T2* mapping, native T1 mapping, dGEMRIC, ΔR1 and value of pre-contrast imaging.

Authors:  Christian Buchbender; Axel Scherer; Patric Kröpil; Birthe Körbl; Michael Quentin; Dorothea Ch Reichelt; Rotem S Lanzman; Christian Mathys; Dirk Blondin; Bernd Bittersohl; Christoph Zilkens; Matthias Hofer; Hans-Jörg Wittsack; Matthias Schneider; Gerald Antoch; Benedikt Ostendorf; Falk Miese
Journal:  Skeletal Radiol       Date:  2011-09-20       Impact factor: 2.199

2.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

3.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

4.  Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.

Authors:  S Elliott; A D Rowan; S Carrère; P Koshy; J B Catterall; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage.

Authors:  L J Croucher; A P Hollander
Journal:  Mol Pathol       Date:  1999-12

6.  Detection of Luse bodies, spiralled collagen, dysplastic collagen, and intracellular collagen in rheumatoid connective tissues: an electron microscopic study.

Authors:  M F Neurath
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

7.  A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents.

Authors:  E H Karran; K Dodgson; S J Harris; R E Markwell; G P Harper
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

8.  Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII).

Authors:  Y Waksman; I Hod; A Friedman
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.

Authors:  A P Hollander; T F Heathfield; C Webber; Y Iwata; R Bourne; C Rorabeck; A R Poole
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.